Veracyte (VCYT)

Common Shares
Sell: $34.35|Buy: $43.43|Change: 0.30 (0.82%)

Company profile

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

Address

6000 Shoreline Court
Suite 300
South San Francisco
CA
USA
94080


Telephone

+1 650 2436300


Sector 

Healthcare


Previous key dates

NameKey Date
Veracyte Inc Annual Report for 20252026-02-27T00:00:00
Veracyte Inc Fourth Quarter Earnings Conference Call for 20252026-02-25T16:30:00
Veracyte Inc Fourth Quarter Earnings Results for 20252026-02-25T00:00:00
44th Annual J.P. Morgan Healthcare Conference2026-01-15T09:45:00
Jefferies Global Healthcare Conference2025-11-20T11:30:00
Stephens Annual Investment Conference2025-11-20T11:00:00
Wolfe Research Healthcare Conference2025-11-17T10:00:00
Veracyte Inc Third Quarter Earnings Conference Call for 20252025-11-04T16:30:00
Veracyte Inc Third Quarter Earnings Results for 20252025-11-04T00:00:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-09T16:50:00
Veracyte Inc Second Quarter Earnings Conference Call for 20252025-08-06T16:30:00
Veracyte Inc Second Quarter Earnings Results for 20252025-08-06T00:00:00
Veracyte Inc Annual General Meeting for 20252025-06-17T10:00:00
Jefferies Global Healthcare Conference2025-06-04T14:00:00
William Blair 45th Annual Growth Stock Conference2025-06-03T17:40:00
Veracyte Inc First Quarter Earnings Conference Call for 20252025-05-07T16:30:00
Veracyte Inc First Quarter Earnings Result for 20252025-05-07T00:00:00
Leerink Partners Global Healthcare Conference2025-03-11T08:40:00
Raymond James 46th Annual Institutional Investors Conference2025-03-05T09:50:00
Veracyte Inc Annual Report for 20242025-02-28T00:00:00
Veracyte Inc Fourth Quarter Earnings Conference Call for 20242025-02-24T16:30:00
Veracyte Inc Fourth Quarter Earnings Result for 20242025-02-24T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.